Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silymarin + B Complex (brand name: ADILIVO-PLUS) is a combination hepatoprotective and nutritional supplement. Silymarin, a standardized extract of flavonolignans from the milk thistle plant (*Silybum marianum*), functions by stabilizing hepatocyte cell membranes, inhibiting lipid peroxidation, and stimulating nucleolar RNA polymerase I, which promotes ribosomal protein synthesis and liver tissue regeneration. The B-complex component provides essential water-soluble vitamins that serve as enzymatic cofactors in the metabolism of carbohydrates, proteins, and fats, supporting the liver's detoxification pathways and overall cellular energy production. It is indicated for the management of various liver conditions, including hepatitis, cirrhosis, and jaundice, and is commonly used as a liver tonic to support digestion and recovery from hepatic injury.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silymarin + b complex.